8-K: Verano Announces Fourth Quarter and Full Year 2024 Financial Results

Verano Holdings Corp. reports a decrease in revenue for both the fourth quarter and full year 2024, alongside a significant net loss, despite growth in adjusted EBITDA and operational expansions.

Summary

• Verano Holdings Corp. announced its financial results for the fourth quarter and full year ended December 31, 2024.
• Fourth quarter revenue was $218 million, down 8% year-over-year but up 1% compared to the prior quarter.
• Full year revenue was $879 million, a decrease of 6% year-over-year.
• The company reported a net loss of $(273) million for the fourth quarter and $(342) million for the full year.
• Adjusted EBITDA was $63 million for the fourth quarter and $264 million for the full year.
• Net cash provided by operating activities was $44 million for the fourth quarter and $112 million for the full year.
• Capital expenditures were $14 million for the fourth quarter and $99 million for the full year.
• The company anticipates 2025 capital expenditures to range between $25 and $40 million.
• Verano expanded its retail footprint in Florida and commenced adult use sales in Connecticut.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company highlights operational expansions and growth in adjusted EBITDA, the significant net loss and revenue decline raise concerns. The forward-looking statements provide some optimism, but the overall picture is mixed.

Positives

• Net cash provided by operating activities increased to $44 million in Q4 from $32 million in the prior year.
• Net cash provided by operating activities increased to $112 million for the full year from $110 million in the prior year.
• Verano expanded its retail footprint in Florida, reaching 80 dispensaries statewide.
• Verano commenced adult use sales at Zen Leaf Waterbury, completing the conversion of all five existing Connecticut Zen Leaf dispensaries.
• The company anticipates 2025 capital expenditures to range between $25 and $40 million.

Negatives

• Fourth quarter revenue decreased by 8% year-over-year to $218 million.
• Full year revenue decreased by 6% year-over-year to $879 million.
• The company experienced a net loss of $(273) million in Q4 and $(342) million for the full year.
• The decrease in revenue for the full year 2024 compared to the full year 2023 was driven primarily by expected declines in Illinois and New Jersey due to increased retail competition, and a temporary shift in cultivation output in Florida.

Risks

• The company cites increased promotional activity and price compression in key markets as drivers for decreased revenue.
• Expected declines in Illinois and New Jersey due to increased retail competition contributed to the decrease in full year revenue.
• A temporary shift in cultivation output in Florida also contributed to the decrease in full year revenue.
• The company's forward-looking statements are subject to various risks and uncertainties, as detailed in their annual report on Form 10-K.

Future Outlook

The company anticipates 2025 capital expenditures to range between $25 and $40 million and aims to harness innovation, automation, and differentiation to fuel continued growth.

Management Comments

• George Archos, Verano founder, Chairman and Chief Executive Officer, stated that the company laid the foundation to strengthen and optimize its core business to pursue long-term growth in 2024.
• Archos expressed confidence in the company's ability to move with speed and agility in pursuit of growth and build Verano into a cannabis powerhouse in 2025 and beyond.

Industry Context

The report reflects the challenges of increased competition and price compression in the cannabis industry, particularly in established markets like Illinois and New Jersey, while also highlighting opportunities for growth through expansion into new markets and product innovation.

Comparison to Industry Standards

• Comparing Verano's performance to other multi-state operators (MSOs) like Curaleaf, Trulieve, and Green Thumb Industries, the revenue decline is a concern, as some competitors have shown more resilience or growth in similar market conditions.
• Verano's adjusted EBITDA margin of 30% for the full year is within the range of other leading MSOs, but the significant net loss raises questions about operational efficiency and asset management.
• The increase in capital expenditures suggests a focus on expansion and infrastructure development, which aligns with industry trends but requires careful management to ensure a return on investment.
• The company's strategic initiatives, such as entering the Virginia market and expanding in Florida, are consistent with the broader industry trend of seeking growth in emerging and expanding cannabis markets.

Stakeholder Impact

• Shareholders may be concerned about the net loss and revenue decline, but reassured by the growth in adjusted EBITDA and the company's strategic initiatives.
• Employees may be affected by operational and headcount optimization efforts.
• Customers will benefit from new product extensions and expanded retail locations.
• Suppliers and creditors may be impacted by the company's financial performance and capital expenditure plans.

Next Steps

• The company plans to focus on innovation, automation, and differentiation to fuel continued growth.
• Verano will continue to expand its retail footprint and product offerings in key markets.
• The company will host a conference call and webcast on February 27, 2025, to discuss the results and answer investor questions.

Key Dates